Home › Funds › Longaeva Partners L.P. › UTHR
Longaeva Partners L.P. position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Longaeva Partners L.P. reported holding 100,000 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$54.2M, representing 1.37% of its reported portfolio and ranking #7 among its reported holdings. Longaeva Partners L.P. first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Longaeva Partners L.P.'s UTHR position evolved
Longaeva Partners L.P. first disclosed a stake in UTHR in Q3 2026 at 100,000 shares (US$54.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 100.00K | $54.19M | New |
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 38 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.49B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.76M sh · $1.49B · Q3 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 540.60K sh · $292.94M · Q3 2026
- Vestal Point Capital, LP 475.00K sh · $257.40M · Q3 2026
- Eversept Partners, LP 324.73K sh · $175.97M · Q3 2026
- Deep Track Capital, LP 300.04K sh · $162.59M · Q3 2026
- Soleus Capital Management, L.P. 259.00K sh · $140.35M · Q3 2026
More on Longaeva Partners L.P.
FAQ
How long has Longaeva Partners L.P. held UTHR?
Longaeva Partners L.P. has disclosed UTHR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Longaeva Partners L.P.'s current position in UTHR?
As of Q3 2026, Longaeva Partners L.P. holds 100.00K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $54.19M, representing 1.37% of its reported portfolio and ranking #7.
Has Longaeva Partners L.P. been buying or selling UTHR?
In the latest 13F filing (Q3 2026), Longaeva Partners L.P. newly opened its position in UTHR.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.